[THE INVESTOR] As of June 30 09:40 A.M., Dongkook Pharmaceutical declined 1.42%, compared with yesterday, to 62,700 won. It had declined 8.2% through the past month. Standard deviation, the volatility index for stock price, was 2.1% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, even though the monthly earnings rate of Dongkook Pharmaceutical recorded negative, its volatility for 1 month was proper. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -3.9%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 4.0, and thus it is hard to say that the industrial comparison performance was positive.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.